Trial intelligence / Profile preview

Ciprofloxacin plus fluocinolone otic solution for pediatric acute otitis media with tympanostomy tubes

2010-023239-40Phase 3Completed

Sponsor
Laboratorios Salvat
Start
Sep 2011
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute otitis media (AOM) comparing Ciprofloxacin + fluocinolone acetonide otic solution, Ciprofloxacin otic solution and Fluocinolone acetonide otic solution (3 arms). Primary endpoint: Time to cessation of otorrhea. Started Sep 2011; status: completed.

02

Drugs

ciprofloxacinfluocinolone
03

Conditions

acute otitis media (AOM)

Beyond the preview

Go deeper on 2010-023239-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023239-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call